GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.
The current price of SMFR is $0.31 USD — it has increased by +26.78% in the past 24 hours. Watch Sema4 stock price performance more closely on the chart.
What is Sema4 stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Sema4 stocks are traded under the ticker SMFR.
What is Sema4 market cap?▼
Today Sema4 has the market capitalization of 118.23M
What is Sema4 revenue for the last year?▼
Sema4 revenue for the last year amounts to 173.34M USD.
What is Sema4 net income for the last year?▼
SMFR net income for the last year is -338.37M USD.
How many employees does Sema4 have?▼
As of April 02, 2026, the company has 1,000 employees.